MedTrace Logo

A Prospective Evaluation of Infraorbital Filler Injection

NCT05694286 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2025-01-08

Study results available
· View outcomes & findings →

Summary

The goal of this clinical trial is to measure the facial volumetric changes over time in patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC filler and asked to return for 3D photography at 2 weeks, 1 month, and 3 months post-injection.

Conditions

  • Dermal Filler
  • Rejuvenation

Interventions

PROCEDURE

Juvederm Volbella XC hyaluronic acid dermal filler injection

Infraorbital filler injection

Sponsors & Collaborators

Principal Investigators

  • Ivona Percec, MD, PhD · Penn Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-06
Primary Completion
2023-04-29
Completion
2023-06-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05694286 on ClinicalTrials.gov